AHZ is clearly NOT breaking out anywhere.
without better earnings guidance AHZ could suffer a decline. Maybe AHZ manufacturing and marketing Cardiocel is the wrong approach. There's something wrong here with AHZ sp. The market will lose patience with a company who've only signed up a handful of surgeons. Say what you like about the efficacy of the patch, but so far it's small time stuff.
breaking out, page-74
-
- There are more pages in this discussion • 78 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$11.50 |
Change
0.070(0.61%) |
Mkt cap ! $243.1M | |||
| Open | High | Low | Value | Volume |
| $11.45 | $11.50 | $11.32 | $90.21K | 7.885K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 53 | $11.26 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $11.50 | 2061 | 1 |
View Market Depth
| Last trade - 16.10pm 15/10/2024 (20 minute delay) ? |
| AVR (ASX) Chart |